Biology · Year 13 · Recombinant DNA Technology and Gene Editing · Summer Term

Gene Therapy Approaches

Explore different strategies for gene therapy, including in vivo and ex vivo methods.

• National Curriculum Attainment Targets
• A-Level: Biology - Recombinant DNA Technology
• A-Level: Biology - Gene Therapy

About This Topic

Gene therapy represents a groundbreaking approach to treating genetic diseases by modifying an individual's genes. Students will investigate two primary strategies: in vivo and ex vivo gene therapy. In vivo therapy involves directly introducing therapeutic genes into the patient's body, targeting specific cells or tissues. Ex vivo therapy, conversely, involves modifying cells outside the body and then reintroducing them to the patient. This distinction is crucial for understanding the logistical and biological challenges inherent in each method.

Key to gene therapy's success are the delivery mechanisms, often employing viral vectors, and the precise targeting of affected cells. Students will analyze the advantages and disadvantages of various delivery systems, considering factors like efficiency, immunogenicity, and potential for off-target effects. Evaluating the ethical implications and the current limitations of gene therapy, such as the risk of insertional mutagenesis and immune responses, is also a critical component of this topic. Understanding these complexities provides a realistic perspective on the potential and future of this transformative medical field.

Active learning is particularly beneficial for gene therapy as it allows students to grapple with complex, multi-step processes and abstract concepts. Hands-on modeling of vector delivery or case study analysis of successful and unsuccessful therapies can make the theoretical aspects more concrete and memorable.

Key Questions

1. Compare the advantages and disadvantages of in vivo and ex vivo gene therapy approaches.
2. Analyze the challenges associated with delivering therapeutic genes to target cells.
3. Evaluate the potential and limitations of gene therapy for treating genetic diseases.

Watch Out for These Misconceptions

Common Misconception

Gene therapy can instantly cure any genetic disease.

What to Teach Instead

Gene therapy is a complex, often long-term treatment with varying success rates. Active learning through case studies helps students see that outcomes are not always immediate or complete, and that challenges like immune response or vector delivery can affect efficacy.

Common Misconception

All viral vectors used in gene therapy are equally safe and effective.

What to Teach Instead

Different viral vectors have distinct properties affecting their safety and efficiency. Students can investigate these differences through research and presentations, realizing that vector choice is a critical, nuanced decision in gene therapy design.

Active Learning Ideas

Format Name: Gene Therapy Strategy Debate

Divide students into groups to research and debate the pros and cons of in vivo versus ex vivo gene therapy for a specific genetic disorder. Each group presents their case, followed by a Q&A session.

60 min·Small Groups

Format Name: Vector Design Challenge

Students design a hypothetical viral vector for gene therapy, considering target cell specificity, payload capacity, and safety features. They present their designs and justify their choices.

45 min·Individual

Format Name: Case Study Analysis

Provide students with case studies of patients who have undergone gene therapy. They analyze the treatment approach, outcomes, and any complications, discussing the effectiveness and challenges.

50 min·Pairs

Frequently Asked Questions

What are the main differences between in vivo and ex vivo gene therapy?

In vivo gene therapy delivers therapeutic genes directly into the patient's body, targeting cells within the organism. Ex vivo therapy involves removing cells from the patient, genetically modifying them in a lab, and then returning them. The choice depends on the disease, target cells, and desired treatment strategy.

What are the biggest challenges in delivering therapeutic genes?

Challenges include ensuring the gene reaches the correct target cells, avoiding immune responses to the delivery vector, preventing insertional mutagenesis (where the gene disrupts other genes), and achieving sustained expression of the therapeutic gene. Viral vectors are common but not without risks.

How can students actively engage with the concept of gene therapy?

Active learning methods like debating the merits of in vivo versus ex vivo approaches, designing hypothetical vectors, or analyzing real-world case studies allow students to grapple with the complexities. These activities move beyond rote memorization to foster critical thinking about the potential and limitations of gene therapy.

What is the potential of gene therapy for treating genetic diseases?

Gene therapy holds immense potential for treating inherited disorders by correcting the underlying genetic defect. It offers hope for conditions previously untreatable, such as cystic fibrosis, sickle cell anemia, and certain types of cancer. However, significant research and development are still needed to overcome current limitations.